Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in JAMA. Gastroparesis is a disease of the muscles of the stomach or the nerves controlling the muscles that causes the muscles to stop working, which can result in inadequate grinding of food by the stomach and poor emptying of food from the stomach into the intestine.
Gastroparesis remains a challenging syndrome to manage, with few effective treatments and a lack of rigorously controlled trials. One possible approach to treatment is based on the hypothesis that some of the symptoms (e.g., nausea, pain) arise because of changes in certain nerves. Tricyclic antidepressants are a category of drug often used to treat refractory (not yielding readily to treatment) symptoms of nausea, vomiting, and abdominal pain, according to background information in the article.
Henry P. Parkman, M.D., of Temple University, Philadelphia, and colleagues randomized 130 patients with idiopathic gastroparesis to nortriptyline (n = 65) or placebo (n = 65) to determine whether treatment with the tricyclic antidepressant nortriptyline would result in improvement of symptoms. Study drug dose was increased at 3-week intervals. The primary outcome measure was a decrease in the patient's Gastroparesis Cardinal Symptom Index (GCSI) score of at least 50 percent on 2 consecutive visits during 15 weeks of treatment.
The researchers found that the proportion of patients experiencing symptomatic improvement on 2 visits did not differ between the treatment groups: 15 (23 percent) in the nortriptyline group vs. 14 (21 percent) in the placebo group. There were also no treatment group differences in measures of nausea, fullness or early satiety, or bloating. Treatment was stopped more often in the nortriptyline group (29 percent) than in the placebo group (9 percent), but numbers of adverse events were not different.
"Our results raise general doubts about the utility of tricyclic antidepressants in low doses as a strategy for the treatment of idiopathic gastroparesis," the authors conclude.
Effect of Nortriptyline on Symptoms of Idiopathic Gastroparesis - The NORIG Randomized Clinical Trial, Henry P. Parkman, MD; Mark L. Van Natta, MHS; Thomas L. Abell, MD; Richard W. McCallum, MD; Irene Sarosiek, MD; Linda Nguyen, MD; William J. Snape, MD; Kenneth L. Koch, MD; William L. Hasler, MD; Gianrico Farrugia, MD; Linda Lee, MD; Aynur Unalp-Arida, MD, PhD2; James Tonascia, PhD; Frank Hamilton, MD, MPH; Pankaj J. Pasricha, MD, JAMA. 2013;310(24):2640-2649. doi:10.1001/jama.2013.282833
This trial, from the Gastroparesis Clinical Research Consortium, is supported by National Institute of Diabetes and Digestive and Kidney Diseases grants. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our GastroIntestinal / Gastroenterology category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
The JAMA Network Journals. "Use of antidepressant does not improve symptoms from stomach disorder." Medical News Today. MediLexicon, Intl., 30 Dec. 2013. Web.
8 Mar. 2014. <http://www.medicalnewstoday.com/releases/270661>
The JAMA Network Journals. (2013, December 30). "Use of antidepressant does not improve symptoms from stomach disorder." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/270661.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.